Latest Materials News

WAM Active Limited has announced a significant capital raising through a pro-rata entitlement offer and a placement, aiming to bolster its investment capacity without materially affecting company control.

Green360 Technologies has made significant strides in commercialising its low-carbon cement product Eco-Clay, delivering successful large-scale trials and securing a robust financial footing heading into 2026.

OzAurum Resources has raised $4.1 million through a strategic placement to Forrestania Resources, which now holds a near-20% stake. The funds will accelerate heap leach development at the James Stage 1 Open Pit in Western Australia.

OzAurum Resources has raised $4.1 million through a strategic placement to Forrestania Resources, which will become a significant shareholder and support development at the James Stage 1 Open Pit in Western Australia.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

Alexium International Group has acquired Microtek Laboratories’ microencapsulation business, marking a strategic pivot to manufacturing-led growth and raising $4.6 million to fund expansion. Despite a slight sales dip, the company is poised for a stronger 2026 with new product lines and military trials underway.

The Star Entertainment Group reported a 6% revenue increase to $301 million and a return to EBITDA profit in Q2 FY26, driven by stable Sydney trading, seasonal Gold Coast strength, and a key Brisbane operator fee. Strategic investments and refinancing efforts mark a pivotal phase for the company.

Livium Ltd has solidified its position in the clean energy recycling sector with new contracts, a key patent, and a $4.5 million capital raise, setting the stage for accelerated growth in lithium-ion battery and rare earth element recycling.

Vital Metals has raised A$12.47 million in the second half of 2025 to fund its Tardiff Pre-Feasibility Study, underpinning the development of its high-grade rare earths project in Canada. The strong investor backing follows a robust July 2025 Scoping Study highlighting significant economic potential.

VBX Limited has reported a significant 51% increase in its Wuudagu bauxite resource and enhanced its project feasibility study, supported by fresh funding and robust market conditions.

QPM Energy has secured key contracts and financing milestones for its 112MW Isaac Power Station, while managing stable gas supply amid weak electricity prices.

Prescient Therapeutics has secured a key regulatory milestone with the EMA granting Orphan Drug Designation for PTX-100 to treat cutaneous T-cell lymphoma, while expanding its Phase 2a clinical trial across multiple continents.